サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566761

免疫診断市場：製品タイプ別、技術別、用途別、エンドユーザー別：世界の機会分析と産業予測、2024～2033年

Immunodiagnostics Market By Product Type , By Technology By Application By End-user : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 280 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
免疫診断市場：製品タイプ別、技術別、用途別、エンドユーザー別：世界の機会分析と産業予測、2024～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 280 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

免疫診断市場は、2023年に242億米ドルと評価され、2024～2033年にかけてCAGR 4.1％で成長し、2033年には364億米ドルに達すると予測されています。

免疫診断は、抗原抗体反応を利用して病原体や異物を同定、標的化、除去する試験です。広範囲の標的を検出する強力な技術として機能するため、感染症や自己免疫疾患の検出、食品安全、がん診断のセグメントで主要な応用が見られます。最も一般的な免疫診断技術には、酵素結合免疫吸着測定法（ELISA）、ラジオイムノアッセイ、蛍光免疫測定法、ラテラルフローアッセイなどがあります。

世界の免疫診断市場の成長は、がん、心血管疾患、胃腸障害などの慢性疾患の有病率が憂慮すべきほど増加していることが主要要因です。さらに、環境汚染の増加や、汚染への高い曝露による疾病の発生率の上昇が、免疫診断の需要を押し上げています。免疫診断ツールは、ジクロロジフェニルトリクロロエタン（DDT）、ポリ塩化ビフェニル（PCB）、爆発物、有機リン系殺虫剤、生物兵器物質などの環境汚染物質の検出において重要な役割を果たしています。さらに、ブドウ球菌性エンテロトキシンBのような食品中の汚染物質や、果物、野菜、穀物中の農薬は、免疫診断法を用いて容易に検出することができます。しかし、免疫診断に関連するコストが高く、新興国では先端技術の導入に消極的であることが、市場成長の妨げになると予想されます。一方、先進的な予防医療に対する意識の高まりや、診断キット、アッセイ、分析装置の技術的進歩は、予測期間中、世界の免疫診断市場の拡大に有益な機会を提供すると期待されています。

世界の免疫診断市場は、製品タイプ、技術、用途、エンドユーザー、地域に区分されます。製品タイプにより、市場は試薬、機器、ソフトウェア＆サービスに分類されます。技術タイプにより、市場は酵素結合免疫吸着測定法、化学発光免疫測定法、蛍光免疫測定法、放射免疫測定法、その他に分類されます。用途別では、感染症、腫瘍・内分泌、骨・ミネラル疾患、自己免疫疾患、心臓バイオマーカー、薬剤モニタリング、その他に細分化されます。エンドユーザー別では、病院、臨床試験室、学術・研究機関、その他に分類されます。地域別では、北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカに分析されます。

主要調査結果

製品タイプ別では、試薬セグメントが2033年までに市場をリードすると予測されます。

技術別では、ELISA技術セグメントが2023年の免疫診断市場を独占します。

用途別では、感染症セグメントが予測期間中に市場を独占する可能性が高いです。

エンドユーザー別では、臨床試験部門が予測期間中に有利になりそうです。

地域別では、北米が2023年の主要収益源であり、予測期間中も市場を独占しそうです。

本レポートで可能なカスタマイズ（追加費用とスケジュールがあります。）

  • 国、地域、世界レベルでの患者/疫学データ
  • 規制ガイドライン
  • 顧客の関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡大リスト
  • 過去の市場データ
  • SWOT分析

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主要調査結果
    • 主要投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 免疫診断市場：製品タイプ別

  • 市場概要
  • 試薬
  • 試験機器
  • ソフトウェアとサービス

第5章 免疫診断市場：技術別

  • 市場概要
  • 酵素結合免疫吸着測定法
  • 化学発光免疫測定法
  • 蛍光免疫測定法
  • ラジオイムノアッセイ
  • その他

第6章 免疫診断市場：用途別

  • 市場概要
  • 感染症
  • 腫瘍学内分泌学
  • 骨ミネラル疾患
  • 自己免疫疾患
  • 心臓バイオマーカー
  • 薬剤モニタリング
  • その他

第7章 免疫診断市場：エンドユーザー別

  • 市場概要
  • 病院
  • 臨床研究所
  • 学術研究機関
  • その他

第8章 免疫診断市場：地域別

  • 市場概要
  • 北米
    • 主要市場動向と機会
    • 米国の免疫診断市場
    • カナダの免疫診断市場
    • メキシコの免疫診断市場
  • 欧州
    • 主要市場動向と機会
    • フランスの免疫診断市場
    • ドイツの免疫診断市場
    • イタリアの免疫診断市場
    • スペインの免疫診断市場
    • 英国の免疫診断市場
    • その他の欧州の免疫診断市場
  • アジア太平洋
    • 主要市場動向と機会
    • 中国の免疫診断市場
    • 日本の免疫診断市場
    • インドの免疫診断市場
    • 韓国の免疫診断市場
    • オーストラリアの免疫診断市場
    • その他のアジア太平洋の免疫診断市場
  • ラテンアメリカ・中東・アフリカ
    • 主要市場動向と機会
    • ブラジルの免疫診断市場
    • 南アフリカの免疫診断市場
    • サウジアラビアの免疫診断市場
    • その他のラテンアメリカ・中東・アフリカの免疫診断市場

第9章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第10章 企業プロファイル

  • Abbott
  • Becton Dickinson
  • Agilent Technologies, Inc.
  • Exact Sciences Corporation
  • Guardant Health
  • Illumina, Inc.
  • Diaosorin
  • NeoGenomics Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
目次
Product Code: A01435

The immunodiagnostics market was valued at $24.2 billion in 2023, and is projected to reach $36.4 billion by 2033, growing at a CAGR of 4.1% from 2024 to 2033.

Immunodiagnostics are tests that involve the use of antigen-antibody responses to identify, target, and eliminate pathogens or foreign substances. It serves as a powerful technique to detect a wide range of targets and thus finds its major application in the fields of infectious diseases and autoimmune disease detection, food safety, and cancer diagnostics. The most common Immunodiagnostics techniques include enzyme-linked immunosorbent assay (ELISA), radioimmunoassays, fluorescent immunoassays, and lateral flow assays.

The growth of the global immunodiagnostics market is majorly driven by alarming increase in prevalence of chronic diseases such as cancer, cardiovascular diseases, gastrointestinal disorders, and other chronic diseases due to vulnerability of geriatric population to such diseases and changes in lifestyle. Furthermore, increase in environmental pollution and rise in incidence of diseases due to high exposure to pollution have boosted the demand for immunodiagnostics. Immunodiagnostic tools play a key role in detecting environmental contaminants such as dichlorodiphenyltrichloroethane (DDT), polychlorinated biphenyls (PCB), explosives, organophosphorus pesticides, and biological warfare materials. In addition, contaminants in food such as Staphylococcal enterotoxin B as well as pesticides in fruits, vegetables, and grains can be easily detected using immunodiagnostics. However, high costs associated with immunodiagnostics and reluctance in the adoption of advanced technologies in emerging economies are expected to hamper the growth of the market. On the contrary, increase in awareness about advanced preventative health measures and technologically advancements in diagnostic kits, assays, and analyzers are expected to offer remunerative opportunities for the expansion of the global immunodiagnostics market during the forecast period.

The global immunodiagnostics market is segmented into product type, technology, application, end user, and region. Depending on product type, the market is classified into reagents, instruments, and software & services.?As per technology, it is segregated into enzyme-linked immunosorbent assay, chemiluminescence immunoassay, fluorescent immunoassay, radioimmunoassay, and others. Depending on application, it is fragmented into infectious diseases, oncology & endocrinology, bone & mineral diseases, autoimmunity disorders, cardiac biomarkers, drug monitoring, and others. By end user, it is categorized into hospitals, clinical laboratories, academic & research institutes, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product type, the reagents segment is expected to lead the market by 2033.

As per technology, the ELISA technology segment dominated the immunodiagnostics market in 2023.

Depending on application, the infectious disease segment is likely to dominate the market during the forecast period.

By end user, the clinical laboratories segment is likely to be lucrative during the forecast period.

Region wise, North America was the major revenue generator in 2023, and is likely to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global immunodiagnostics market include Abbott, Becton Dickinson, Agilent Technologies, Inc., Exact Sciences Corporation, Guardant Health, Illumina, Inc., Diaosorin, NeoGenomics Laboratories, F. Hoffmann-La Roche Ltd., and Thermo Fisher Scientific. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Product Type

  • Reagents
  • Instruments
  • Software and Services

By Technology

  • Enzyme-linked immunosorbent assay
  • Chemiluminescence immunoassay
  • Fluorescent immunoassay
  • Radioimmunoassay
  • Others

By Application

  • Infectious diseases
  • Oncology endocrinology
  • Bone mineral diseases
  • Autoimmunity disorders
  • Cardiac biomarkers
  • Drug monitoring
  • Others

By End-user

  • Hospitals
  • Clinical Laboratories
  • Academic research institutes
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Abbott
    • Becton Dickinson
    • Agilent Technologies, Inc.
    • Exact Sciences Corporation
    • Guardant Health
    • Illumina, Inc.
    • Diaosorin
    • NeoGenomics Laboratories
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product Type
  • 4.2. Reagents
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Instruments
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Software And Services
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Technology
  • 5.2. Enzyme-linked Immunosorbent Assay
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Chemiluminescence Immunoassay
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Fluorescent Immunoassay
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Radioimmunoassay
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. Others
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country

CHAPTER 6: IMMUNODIAGNOSTICS MARKET, BY APPLICATION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Application
  • 6.2. Infectious Diseases
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Oncology Endocrinology
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Bone Mineral Diseases
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Autoimmunity Disorders
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country
  • 6.6. Cardiac Biomarkers
    • 6.6.1. Key Market Trends, Growth Factors and Opportunities
    • 6.6.2. Market Size and Forecast, By Region
    • 6.6.3. Market Share Analysis, By Country
  • 6.7. Drug Monitoring
    • 6.7.1. Key Market Trends, Growth Factors and Opportunities
    • 6.7.2. Market Size and Forecast, By Region
    • 6.7.3. Market Share Analysis, By Country
  • 6.8. Others
    • 6.8.1. Key Market Trends, Growth Factors and Opportunities
    • 6.8.2. Market Size and Forecast, By Region
    • 6.8.3. Market Share Analysis, By Country

CHAPTER 7: IMMUNODIAGNOSTICS MARKET, BY END-USER

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By End-user
  • 7.2. Hospitals
    • 7.2.1. Key Market Trends, Growth Factors and Opportunities
    • 7.2.2. Market Size and Forecast, By Region
    • 7.2.3. Market Share Analysis, By Country
  • 7.3. Clinical Laboratories
    • 7.3.1. Key Market Trends, Growth Factors and Opportunities
    • 7.3.2. Market Size and Forecast, By Region
    • 7.3.3. Market Share Analysis, By Country
  • 7.4. Academic Research Institutes
    • 7.4.1. Key Market Trends, Growth Factors and Opportunities
    • 7.4.2. Market Size and Forecast, By Region
    • 7.4.3. Market Share Analysis, By Country
  • 7.5. Others
    • 7.5.1. Key Market Trends, Growth Factors and Opportunities
    • 7.5.2. Market Size and Forecast, By Region
    • 7.5.3. Market Share Analysis, By Country

CHAPTER 8: IMMUNODIAGNOSTICS MARKET, BY REGION

  • 8.1. Market Overview
    • 8.1.1 Market Size and Forecast, By Region
  • 8.2. North America
    • 8.2.1. Key Market Trends and Opportunities
    • 8.2.2. Market Size and Forecast, By Product Type
    • 8.2.3. Market Size and Forecast, By Technology
    • 8.2.4. Market Size and Forecast, By Application
    • 8.2.5. Market Size and Forecast, By End-user
    • 8.2.6. Market Size and Forecast, By Country
    • 8.2.7. U.S. Immunodiagnostics Market
      • 8.2.7.1. Market Size and Forecast, By Product Type
      • 8.2.7.2. Market Size and Forecast, By Technology
      • 8.2.7.3. Market Size and Forecast, By Application
      • 8.2.7.4. Market Size and Forecast, By End-user
    • 8.2.8. Canada Immunodiagnostics Market
      • 8.2.8.1. Market Size and Forecast, By Product Type
      • 8.2.8.2. Market Size and Forecast, By Technology
      • 8.2.8.3. Market Size and Forecast, By Application
      • 8.2.8.4. Market Size and Forecast, By End-user
    • 8.2.9. Mexico Immunodiagnostics Market
      • 8.2.9.1. Market Size and Forecast, By Product Type
      • 8.2.9.2. Market Size and Forecast, By Technology
      • 8.2.9.3. Market Size and Forecast, By Application
      • 8.2.9.4. Market Size and Forecast, By End-user
  • 8.3. Europe
    • 8.3.1. Key Market Trends and Opportunities
    • 8.3.2. Market Size and Forecast, By Product Type
    • 8.3.3. Market Size and Forecast, By Technology
    • 8.3.4. Market Size and Forecast, By Application
    • 8.3.5. Market Size and Forecast, By End-user
    • 8.3.6. Market Size and Forecast, By Country
    • 8.3.7. France Immunodiagnostics Market
      • 8.3.7.1. Market Size and Forecast, By Product Type
      • 8.3.7.2. Market Size and Forecast, By Technology
      • 8.3.7.3. Market Size and Forecast, By Application
      • 8.3.7.4. Market Size and Forecast, By End-user
    • 8.3.8. Germany Immunodiagnostics Market
      • 8.3.8.1. Market Size and Forecast, By Product Type
      • 8.3.8.2. Market Size and Forecast, By Technology
      • 8.3.8.3. Market Size and Forecast, By Application
      • 8.3.8.4. Market Size and Forecast, By End-user
    • 8.3.9. Italy Immunodiagnostics Market
      • 8.3.9.1. Market Size and Forecast, By Product Type
      • 8.3.9.2. Market Size and Forecast, By Technology
      • 8.3.9.3. Market Size and Forecast, By Application
      • 8.3.9.4. Market Size and Forecast, By End-user
    • 8.3.10. Spain Immunodiagnostics Market
      • 8.3.10.1. Market Size and Forecast, By Product Type
      • 8.3.10.2. Market Size and Forecast, By Technology
      • 8.3.10.3. Market Size and Forecast, By Application
      • 8.3.10.4. Market Size and Forecast, By End-user
    • 8.3.11. UK Immunodiagnostics Market
      • 8.3.11.1. Market Size and Forecast, By Product Type
      • 8.3.11.2. Market Size and Forecast, By Technology
      • 8.3.11.3. Market Size and Forecast, By Application
      • 8.3.11.4. Market Size and Forecast, By End-user
    • 8.3.12. Rest of Europe Immunodiagnostics Market
      • 8.3.12.1. Market Size and Forecast, By Product Type
      • 8.3.12.2. Market Size and Forecast, By Technology
      • 8.3.12.3. Market Size and Forecast, By Application
      • 8.3.12.4. Market Size and Forecast, By End-user
  • 8.4. Asia-Pacific
    • 8.4.1. Key Market Trends and Opportunities
    • 8.4.2. Market Size and Forecast, By Product Type
    • 8.4.3. Market Size and Forecast, By Technology
    • 8.4.4. Market Size and Forecast, By Application
    • 8.4.5. Market Size and Forecast, By End-user
    • 8.4.6. Market Size and Forecast, By Country
    • 8.4.7. China Immunodiagnostics Market
      • 8.4.7.1. Market Size and Forecast, By Product Type
      • 8.4.7.2. Market Size and Forecast, By Technology
      • 8.4.7.3. Market Size and Forecast, By Application
      • 8.4.7.4. Market Size and Forecast, By End-user
    • 8.4.8. Japan Immunodiagnostics Market
      • 8.4.8.1. Market Size and Forecast, By Product Type
      • 8.4.8.2. Market Size and Forecast, By Technology
      • 8.4.8.3. Market Size and Forecast, By Application
      • 8.4.8.4. Market Size and Forecast, By End-user
    • 8.4.9. India Immunodiagnostics Market
      • 8.4.9.1. Market Size and Forecast, By Product Type
      • 8.4.9.2. Market Size and Forecast, By Technology
      • 8.4.9.3. Market Size and Forecast, By Application
      • 8.4.9.4. Market Size and Forecast, By End-user
    • 8.4.10. South Korea Immunodiagnostics Market
      • 8.4.10.1. Market Size and Forecast, By Product Type
      • 8.4.10.2. Market Size and Forecast, By Technology
      • 8.4.10.3. Market Size and Forecast, By Application
      • 8.4.10.4. Market Size and Forecast, By End-user
    • 8.4.11. Australia Immunodiagnostics Market
      • 8.4.11.1. Market Size and Forecast, By Product Type
      • 8.4.11.2. Market Size and Forecast, By Technology
      • 8.4.11.3. Market Size and Forecast, By Application
      • 8.4.11.4. Market Size and Forecast, By End-user
    • 8.4.12. Rest of Asia-Pacific Immunodiagnostics Market
      • 8.4.12.1. Market Size and Forecast, By Product Type
      • 8.4.12.2. Market Size and Forecast, By Technology
      • 8.4.12.3. Market Size and Forecast, By Application
      • 8.4.12.4. Market Size and Forecast, By End-user
  • 8.5. LAMEA
    • 8.5.1. Key Market Trends and Opportunities
    • 8.5.2. Market Size and Forecast, By Product Type
    • 8.5.3. Market Size and Forecast, By Technology
    • 8.5.4. Market Size and Forecast, By Application
    • 8.5.5. Market Size and Forecast, By End-user
    • 8.5.6. Market Size and Forecast, By Country
    • 8.5.7. Brazil Immunodiagnostics Market
      • 8.5.7.1. Market Size and Forecast, By Product Type
      • 8.5.7.2. Market Size and Forecast, By Technology
      • 8.5.7.3. Market Size and Forecast, By Application
      • 8.5.7.4. Market Size and Forecast, By End-user
    • 8.5.8. South Africa Immunodiagnostics Market
      • 8.5.8.1. Market Size and Forecast, By Product Type
      • 8.5.8.2. Market Size and Forecast, By Technology
      • 8.5.8.3. Market Size and Forecast, By Application
      • 8.5.8.4. Market Size and Forecast, By End-user
    • 8.5.9. Saudi Arabia Immunodiagnostics Market
      • 8.5.9.1. Market Size and Forecast, By Product Type
      • 8.5.9.2. Market Size and Forecast, By Technology
      • 8.5.9.3. Market Size and Forecast, By Application
      • 8.5.9.4. Market Size and Forecast, By End-user
    • 8.5.10. Rest of LAMEA Immunodiagnostics Market
      • 8.5.10.1. Market Size and Forecast, By Product Type
      • 8.5.10.2. Market Size and Forecast, By Technology
      • 8.5.10.3. Market Size and Forecast, By Application
      • 8.5.10.4. Market Size and Forecast, By End-user

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top Winning Strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Top Player Positioning, 2023

CHAPTER 10: COMPANY PROFILES

  • 10.1. Abbott
    • 10.1.1. Company Overview
    • 10.1.2. Key Executives
    • 10.1.3. Company Snapshot
    • 10.1.4. Operating Business Segments
    • 10.1.5. Product Portfolio
    • 10.1.6. Business Performance
    • 10.1.7. Key Strategic Moves and Developments
  • 10.2. Becton Dickinson
    • 10.2.1. Company Overview
    • 10.2.2. Key Executives
    • 10.2.3. Company Snapshot
    • 10.2.4. Operating Business Segments
    • 10.2.5. Product Portfolio
    • 10.2.6. Business Performance
    • 10.2.7. Key Strategic Moves and Developments
  • 10.3. Agilent Technologies, Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Key Executives
    • 10.3.3. Company Snapshot
    • 10.3.4. Operating Business Segments
    • 10.3.5. Product Portfolio
    • 10.3.6. Business Performance
    • 10.3.7. Key Strategic Moves and Developments
  • 10.4. Exact Sciences Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Key Executives
    • 10.4.3. Company Snapshot
    • 10.4.4. Operating Business Segments
    • 10.4.5. Product Portfolio
    • 10.4.6. Business Performance
    • 10.4.7. Key Strategic Moves and Developments
  • 10.5. Guardant Health
    • 10.5.1. Company Overview
    • 10.5.2. Key Executives
    • 10.5.3. Company Snapshot
    • 10.5.4. Operating Business Segments
    • 10.5.5. Product Portfolio
    • 10.5.6. Business Performance
    • 10.5.7. Key Strategic Moves and Developments
  • 10.6. Illumina, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Key Executives
    • 10.6.3. Company Snapshot
    • 10.6.4. Operating Business Segments
    • 10.6.5. Product Portfolio
    • 10.6.6. Business Performance
    • 10.6.7. Key Strategic Moves and Developments
  • 10.7. Diaosorin
    • 10.7.1. Company Overview
    • 10.7.2. Key Executives
    • 10.7.3. Company Snapshot
    • 10.7.4. Operating Business Segments
    • 10.7.5. Product Portfolio
    • 10.7.6. Business Performance
    • 10.7.7. Key Strategic Moves and Developments
  • 10.8. NeoGenomics Laboratories
    • 10.8.1. Company Overview
    • 10.8.2. Key Executives
    • 10.8.3. Company Snapshot
    • 10.8.4. Operating Business Segments
    • 10.8.5. Product Portfolio
    • 10.8.6. Business Performance
    • 10.8.7. Key Strategic Moves and Developments
  • 10.9. F. Hoffmann-La Roche Ltd.
    • 10.9.1. Company Overview
    • 10.9.2. Key Executives
    • 10.9.3. Company Snapshot
    • 10.9.4. Operating Business Segments
    • 10.9.5. Product Portfolio
    • 10.9.6. Business Performance
    • 10.9.7. Key Strategic Moves and Developments
  • 10.10. Thermo Fisher Scientific Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Key Executives
    • 10.10.3. Company Snapshot
    • 10.10.4. Operating Business Segments
    • 10.10.5. Product Portfolio
    • 10.10.6. Business Performance
    • 10.10.7. Key Strategic Moves and Developments